img

Global Oral Peptide Therapy Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Oral Peptide Therapy Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

The drugs give through oral.
Oral Peptide Therapy report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Oral Peptide Therapy market is projected to reach US$ 7980.1 million in 2029, increasing from US$ 2000 million in 2022, with the CAGR of 15.0% during the period of 2024 to 2029. Demand from Hospital and Retail Pharmacy are the major drivers for the industry.
The Peptide Drug market is driven by the increasing recognition of peptides as a versatile and promising class of therapeutics. Peptides offer the potential to target specific biological pathways and cellular functions with high specificity, making them valuable candidates for treating a wide range of diseases, including cancer, metabolic disorders, and cardiovascular conditions. The growing understanding of peptide structure-activity relationships, coupled with advancements in peptide synthesis and modification techniques, contribute to the development of more stable and bioavailable peptide drugs, fostering market growth. Moreover, the rise in personalized medicine approaches and the need for more targeted therapies align with the development of peptide-based treatments that can be tailored to individual patient profiles. However, the market also faces challenges, including optimizing peptide delivery systems, enhancing bioavailability, and addressing potential immunogenicity and stability issues. Additionally, the complexity of peptide synthesis, the need for stringent regulatory approvals, and the competition from other therapeutic modalities pose obstacles for manufacturers and researchers. To succeed, stakeholders must focus on innovative peptide design, efficient synthesis methods, and comprehensive pre-clinical and clinical studies to demonstrate the safety and efficacy of peptide drugs. Addressing challenges while harnessing the therapeutic potential of peptides will be essential for driving the growth and adoption of peptide-based treatments in various medical applications.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Oral Peptide Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Allergan
Novo Nordisk
Synergy Pharmaceuticals （Salix）
Novartis
Chiasma
Segment by Type
Linaclotide
Insulin
Plecanatide
Cyclosporine
Octreotide

Segment by Application


Hospital
Retail Pharmacy

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Oral Peptide Therapy market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Oral Peptide Therapy, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Oral Peptide Therapy industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Oral Peptide Therapy in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Oral Peptide Therapy introduction, etc. Oral Peptide Therapy Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Oral Peptide Therapy market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Oral Peptide Therapy Market Overview
1.1 Oral Peptide Therapy Product Overview
1.2 Oral Peptide Therapy Market Segment by Type
1.2.1 Linaclotide
1.2.2 Insulin
1.2.3 Plecanatide
1.2.4 Cyclosporine
1.2.5 Octreotide
1.3 Global Oral Peptide Therapy Market Size by Type
1.3.1 Global Oral Peptide Therapy Market Size Overview by Type (2018-2029)
1.3.2 Global Oral Peptide Therapy Historic Market Size Review by Type (2018-2024)
1.3.3 Global Oral Peptide Therapy Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Oral Peptide Therapy Sales Breakdown by Type (2018-2024)
1.4.2 Europe Oral Peptide Therapy Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Oral Peptide Therapy Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Oral Peptide Therapy Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Oral Peptide Therapy Sales Breakdown by Type (2018-2024)
2 Global Oral Peptide Therapy Market Competition by Company
2.1 Global Top Players by Oral Peptide Therapy Sales (2018-2024)
2.2 Global Top Players by Oral Peptide Therapy Revenue (2018-2024)
2.3 Global Top Players by Oral Peptide Therapy Price (2018-2024)
2.4 Global Top Manufacturers Oral Peptide Therapy Manufacturing Base Distribution, Sales Area, Product Type
2.5 Oral Peptide Therapy Market Competitive Situation and Trends
2.5.1 Oral Peptide Therapy Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Oral Peptide Therapy Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oral Peptide Therapy as of 2022)
2.7 Date of Key Manufacturers Enter into Oral Peptide Therapy Market
2.8 Key Manufacturers Oral Peptide Therapy Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Oral Peptide Therapy Status and Outlook by Region
3.1 Global Oral Peptide Therapy Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Oral Peptide Therapy Historic Market Size by Region
3.2.1 Global Oral Peptide Therapy Sales in Volume by Region (2018-2024)
3.2.2 Global Oral Peptide Therapy Sales in Value by Region (2018-2024)
3.2.3 Global Oral Peptide Therapy Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Oral Peptide Therapy Forecasted Market Size by Region
3.3.1 Global Oral Peptide Therapy Sales in Volume by Region (2024-2029)
3.3.2 Global Oral Peptide Therapy Sales in Value by Region (2024-2029)
3.3.3 Global Oral Peptide Therapy Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Oral Peptide Therapy by Application
4.1 Oral Peptide Therapy Market Segment by Application
4.1.1 Hospital
4.1.2 Retail Pharmacy
4.2 Global Oral Peptide Therapy Market Size by Application
4.2.1 Global Oral Peptide Therapy Market Size Overview by Application (2018-2029)
4.2.2 Global Oral Peptide Therapy Historic Market Size Review by Application (2018-2024)
4.2.3 Global Oral Peptide Therapy Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Oral Peptide Therapy Sales Breakdown by Application (2018-2024)
4.3.2 Europe Oral Peptide Therapy Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Oral Peptide Therapy Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Oral Peptide Therapy Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Oral Peptide Therapy Sales Breakdown by Application (2018-2024)
5 North America Oral Peptide Therapy by Country
5.1 North America Oral Peptide Therapy Historic Market Size by Country
5.1.1 North America Oral Peptide Therapy Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Oral Peptide Therapy Sales in Volume by Country (2018-2024)
5.1.3 North America Oral Peptide Therapy Sales in Value by Country (2018-2024)
5.2 North America Oral Peptide Therapy Forecasted Market Size by Country
5.2.1 North America Oral Peptide Therapy Sales in Volume by Country (2024-2029)
5.2.2 North America Oral Peptide Therapy Sales in Value by Country (2024-2029)
6 Europe Oral Peptide Therapy by Country
6.1 Europe Oral Peptide Therapy Historic Market Size by Country
6.1.1 Europe Oral Peptide Therapy Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Oral Peptide Therapy Sales in Volume by Country (2018-2024)
6.1.3 Europe Oral Peptide Therapy Sales in Value by Country (2018-2024)
6.2 Europe Oral Peptide Therapy Forecasted Market Size by Country
6.2.1 Europe Oral Peptide Therapy Sales in Volume by Country (2024-2029)
6.2.2 Europe Oral Peptide Therapy Sales in Value by Country (2024-2029)
7 Asia-Pacific Oral Peptide Therapy by Region
7.1 Asia-Pacific Oral Peptide Therapy Historic Market Size by Region
7.1.1 Asia-Pacific Oral Peptide Therapy Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Oral Peptide Therapy Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Oral Peptide Therapy Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Oral Peptide Therapy Forecasted Market Size by Region
7.2.1 Asia-Pacific Oral Peptide Therapy Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Oral Peptide Therapy Sales in Value by Region (2024-2029)
8 Latin America Oral Peptide Therapy by Country
8.1 Latin America Oral Peptide Therapy Historic Market Size by Country
8.1.1 Latin America Oral Peptide Therapy Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Oral Peptide Therapy Sales in Volume by Country (2018-2024)
8.1.3 Latin America Oral Peptide Therapy Sales in Value by Country (2018-2024)
8.2 Latin America Oral Peptide Therapy Forecasted Market Size by Country
8.2.1 Latin America Oral Peptide Therapy Sales in Volume by Country (2024-2029)
8.2.2 Latin America Oral Peptide Therapy Sales in Value by Country (2024-2029)
9 Middle East and Africa Oral Peptide Therapy by Country
9.1 Middle East and Africa Oral Peptide Therapy Historic Market Size by Country
9.1.1 Middle East and Africa Oral Peptide Therapy Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Oral Peptide Therapy Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Oral Peptide Therapy Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Oral Peptide Therapy Forecasted Market Size by Country
9.2.1 Middle East and Africa Oral Peptide Therapy Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Oral Peptide Therapy Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Allergan
10.1.1 Allergan Company Information
10.1.2 Allergan Introduction and Business Overview
10.1.3 Allergan Oral Peptide Therapy Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Allergan Oral Peptide Therapy Products Offered
10.1.5 Allergan Recent Development
10.2 Novo Nordisk
10.2.1 Novo Nordisk Company Information
10.2.2 Novo Nordisk Introduction and Business Overview
10.2.3 Novo Nordisk Oral Peptide Therapy Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Novo Nordisk Oral Peptide Therapy Products Offered
10.2.5 Novo Nordisk Recent Development
10.3 Synergy Pharmaceuticals （Salix）
10.3.1 Synergy Pharmaceuticals （Salix） Company Information
10.3.2 Synergy Pharmaceuticals （Salix） Introduction and Business Overview
10.3.3 Synergy Pharmaceuticals （Salix） Oral Peptide Therapy Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Synergy Pharmaceuticals （Salix） Oral Peptide Therapy Products Offered
10.3.5 Synergy Pharmaceuticals （Salix） Recent Development
10.4 Novartis
10.4.1 Novartis Company Information
10.4.2 Novartis Introduction and Business Overview
10.4.3 Novartis Oral Peptide Therapy Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Novartis Oral Peptide Therapy Products Offered
10.4.5 Novartis Recent Development
10.5 Chiasma
10.5.1 Chiasma Company Information
10.5.2 Chiasma Introduction and Business Overview
10.5.3 Chiasma Oral Peptide Therapy Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Chiasma Oral Peptide Therapy Products Offered
10.5.5 Chiasma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Oral Peptide Therapy Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Oral Peptide Therapy Industrial Chain Analysis
11.4 Oral Peptide Therapy Market Dynamics
11.4.1 Oral Peptide Therapy Industry Trends
11.4.2 Oral Peptide Therapy Market Drivers
11.4.3 Oral Peptide Therapy Market Challenges
11.4.4 Oral Peptide Therapy Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Oral Peptide Therapy Distributors
12.3 Oral Peptide Therapy Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Linaclotide
Table 2. Major Company of Insulin
Table 3. Major Company of Plecanatide
Table 4. Major Company of Cyclosporine
Table 5. Major Company of Octreotide
Table 6. Global Oral Peptide Therapy Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Oral Peptide Therapy Sales by Type (2018-2024) & (K Units)
Table 8. Global Oral Peptide Therapy Sales Market Share in Volume by Type (2018-2024)
Table 9. Global Oral Peptide Therapy Sales by Type (2018-2024) & (US& Million)
Table 10. Global Oral Peptide Therapy Market Share in Value by Type (2018-2024)
Table 11. Global Oral Peptide Therapy Price by Type (2018-2024) & (US$/Unit)
Table 12. Global Oral Peptide Therapy Sales by Type (2024-2029) & (K Units)
Table 13. Global Oral Peptide Therapy Sales Market Share in Volume by Type (2024-2029)
Table 14. Global Oral Peptide Therapy Sales by Type (2024-2029) & (US$ Million)
Table 15. Global Oral Peptide Therapy Sales Market Share in Value by Type (2024-2029)
Table 16. Global Oral Peptide Therapy Price by Type (2024-2029) & (US$/Unit)
Table 17. North America Oral Peptide Therapy Sales by Type (2018-2024) & (K Units)
Table 18. North America Oral Peptide Therapy Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe Oral Peptide Therapy Sales (K Units) by Type (2018-2024)
Table 20. Europe Oral Peptide Therapy Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific Oral Peptide Therapy Sales (K Units) by Type (2018-2024)
Table 22. Asia-Pacific Oral Peptide Therapy Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America Oral Peptide Therapy Sales (K Units) by Type (2018-2024)
Table 24. Latin America Oral Peptide Therapy Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa Oral Peptide Therapy Sales (K Units) by Type (2018-2024)
Table 26. Middle East and Africa Oral Peptide Therapy Sales by Type (2018-2024) & (US$ Million)
Table 27. Global Oral Peptide Therapy Sales by Company (2018-2024) & (K Units)
Table 28. Global Oral Peptide Therapy Sales Share by Company (2018-2024)
Table 29. Global Oral Peptide Therapy Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global Oral Peptide Therapy Revenue Share by Company (2018-2024)
Table 31. Global Market Oral Peptide Therapy Price by Company (2018-2024) & (US$/Unit)
Table 32. Global Oral Peptide Therapy Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Oral Peptide Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oral Peptide Therapy as of 2022)
Table 35. Date of Key Manufacturers Enter into Oral Peptide Therapy Market
Table 36. Key Manufacturers Oral Peptide Therapy Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Oral Peptide Therapy Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Global Oral Peptide Therapy Sales by Region (2018-2024) & (K Units)
Table 40. Global Oral Peptide Therapy Sales Market Share in Volume by Region (2018-2024)
Table 41. Global Oral Peptide Therapy Sales by Region (2018-2024) & (US$ Million)
Table 42. Global Oral Peptide Therapy Sales Market Share in Value by Region (2018-2024)
Table 43. Global Oral Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 44. Global Oral Peptide Therapy Sales by Region (2024-2029) & (K Units)
Table 45. Global Oral Peptide Therapy Sales Market Share in Volume by Region (2024-2029)
Table 46. Global Oral Peptide Therapy Sales by Region (2024-2029) & (US$ Million)
Table 47. Global Oral Peptide Therapy Sales Market Share in Value by Region (2024-2029)
Table 48. Global Oral Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 49. Global Oral Peptide Therapy Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 50. Global Oral Peptide Therapy Sales by Application (2018-2024) & (K Units)
Table 51. Global Oral Peptide Therapy Sales Market Share in Volume by Application (2018-2024)
Table 52. Global Oral Peptide Therapy Sales by Application (2018-2024) & (US$ Million)
Table 53. Global Oral Peptide Therapy Sales Market Share in Value by Application (2018-2024)
Table 54. Global Oral Peptide Therapy Price by Application (2018-2024) & (US$/Unit)
Table 55. Global Oral Peptide Therapy Sales by Application (2024-2029) & (K Units)
Table 56. Global Oral Peptide Therapy Sales Market Share in Volume by Application (2024-2029)
Table 57. Global Oral Peptide Therapy Sales by Application (2024-2029) & (US$ Million)
Table 58. Global Oral Peptide Therapy Sales Market Share in Value by Application (2024-2029)
Table 59. Global Oral Peptide Therapy Price by Application (2024-2029) & (US$/Unit)
Table 60. North America Oral Peptide Therapy Sales by Application (2018-2024) (K Units)
Table 61. North America Oral Peptide Therapy Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe Oral Peptide Therapy Sales by Application (2018-2024) (K Units)
Table 63. Europe Oral Peptide Therapy Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific Oral Peptide Therapy Sales by Application (2018-2024) (K Units)
Table 65. Asia-Pacific Oral Peptide Therapy Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America Oral Peptide Therapy Sales by Application (2018-2024) (K Units)
Table 67. Latin America Oral Peptide Therapy Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa Oral Peptide Therapy Sales by Application (2018-2024) (K Units)
Table 69. Middle East and Africa Oral Peptide Therapy Sales by Application (2018-2024) & (US$ Million)
Table 70. North America Oral Peptide Therapy Sales by Country (2018-2024) & (K Units)
Table 71. North America Oral Peptide Therapy Sales Market Share in Volume by Country (2018-2024)
Table 72. North America Oral Peptide Therapy Sales by Country (2018-2024) & (US$ Million)
Table 73. North America Oral Peptide Therapy Sales Market Share in Value by Country (2018-2024)
Table 74. North America Oral Peptide Therapy Sales by Country (2024-2029) & (K Units)
Table 75. North America Oral Peptide Therapy Sales Market Share in Volume by Country (2024-2029)
Table 76. North America Oral Peptide Therapy Sales by Country (2024-2029) & (US$ Million)
Table 77. North America Oral Peptide Therapy Sales Market Share in Value by Country (2024-2029)
Table 78. Europe Oral Peptide Therapy Sales by Country (2018-2024) & (K Units)
Table 79. Europe Oral Peptide Therapy Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe Oral Peptide Therapy Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe Oral Peptide Therapy Sales Market Share in Value by Country (2018-2024)
Table 82. Europe Oral Peptide Therapy Sales by Country (2024-2029) & (K Units)
Table 83. Europe Oral Peptide Therapy Sales Market Share in Volume by Country (2024-2029)
Table 84. Europe Oral Peptide Therapy Sales by Country (2024-2029) & (US$ Million)
Table 85. Europe Oral Peptide Therapy Sales Market Share in Value by Country (2024-2029)
Table 86. Asia-Pacific Oral Peptide Therapy Sales by Region (2018-2024) & (K Units)
Table 87. Asia-Pacific Oral Peptide Therapy Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific Oral Peptide Therapy Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific Oral Peptide Therapy Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific Oral Peptide Therapy Sales by Region (2024-2029) & (K Units)
Table 91. Asia-Pacific Oral Peptide Therapy Sales Market Share in Volume by Region (2024-2029)
Table 92. Asia-Pacific Oral Peptide Therapy Sales by Region (2024-2029) & (US$ Million)
Table 93. Asia-Pacific Oral Peptide Therapy Sales Market Share in Value by Region (2024-2029)
Table 94. Latin America Oral Peptide Therapy Sales by Country (2018-2024) & (K Units)
Table 95. Latin America Oral Peptide Therapy Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America Oral Peptide Therapy Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America Oral Peptide Therapy Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America Oral Peptide Therapy Sales by Country (2024-2029) & (K Units)
Table 99. Latin America Oral Peptide Therapy Sales Market Share in Volume by Country (2024-2029)
Table 100. Latin America Oral Peptide Therapy Sales by Country (2024-2029) & (US$ Million)
Table 101. Latin America Oral Peptide Therapy Sales Market Share in Value by Country (2024-2029)
Table 102. Middle East and Africa Oral Peptide Therapy Sales by Country (2018-2024) & (K Units)
Table 103. Middle East and Africa Oral Peptide Therapy Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa Oral Peptide Therapy Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa Oral Peptide Therapy Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa Oral Peptide Therapy Sales by Country (2024-2029) & (K Units)
Table 107. Middle East and Africa Oral Peptide Therapy Sales Market Share in Volume by Country (2024-2029)
Table 108. Middle East and Africa Oral Peptide Therapy Sales by Country (2024-2029) & (US$ Million)
Table 109. Middle East and Africa Oral Peptide Therapy Sales Market Share in Value by Country (2024-2029)
Table 110. Allergan Company Information
Table 111. Allergan Introduction and Business Overview
Table 112. Allergan Oral Peptide Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Allergan Oral Peptide Therapy Product
Table 114. Allergan Recent Development
Table 115. Novo Nordisk Company Information
Table 116. Novo Nordisk Introduction and Business Overview
Table 117. Novo Nordisk Oral Peptide Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Novo Nordisk Oral Peptide Therapy Product
Table 119. Novo Nordisk Recent Development
Table 120. Synergy Pharmaceuticals （Salix） Company Information
Table 121. Synergy Pharmaceuticals （Salix） Introduction and Business Overview
Table 122. Synergy Pharmaceuticals （Salix） Oral Peptide Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Synergy Pharmaceuticals （Salix） Oral Peptide Therapy Product
Table 124. Synergy Pharmaceuticals （Salix） Recent Development
Table 125. Novartis Company Information
Table 126. Novartis Introduction and Business Overview
Table 127. Novartis Oral Peptide Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Novartis Oral Peptide Therapy Product
Table 129. Novartis Recent Development
Table 130. Chiasma Company Information
Table 131. Chiasma Introduction and Business Overview
Table 132. Chiasma Oral Peptide Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Chiasma Oral Peptide Therapy Product
Table 134. Chiasma Recent Development
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Oral Peptide Therapy Market Trends
Table 138. Oral Peptide Therapy Market Drivers
Table 139. Oral Peptide Therapy Market Challenges
Table 140. Oral Peptide Therapy Market Restraints
Table 141. Oral Peptide Therapy Distributors List
Table 142. Oral Peptide Therapy Downstream Customers
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Peptide Therapy Product Picture
Figure 2. Global Oral Peptide Therapy Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Oral Peptide Therapy Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Oral Peptide Therapy Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Linaclotide
Figure 6. Global Linaclotide Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Insulin
Figure 8. Global Insulin Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of Plecanatide
Figure 10. Global Plecanatide Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Product Picture of Cyclosporine
Figure 12. Global Cyclosporine Sales YoY Growth (2018-2029) & (K Units)
Figure 13. Product Picture of Octreotide
Figure 14. Global Octreotide Sales YoY Growth (2018-2029) & (K Units)
Figure 15. Global Oral Peptide Therapy Sales by Type (2018-2029) & (US$ Million)
Figure 16. Global Oral Peptide Therapy Sales Market Share by Type in 2022 & 2029
Figure 17. North America Oral Peptide Therapy Sales Market Share in Volume by Type in 2022
Figure 18. North America Oral Peptide Therapy Sales Market Share in Value by Type in 2022
Figure 19. Europe Oral Peptide Therapy Sales Market Share in Volume by Type in 2022
Figure 20. Europe Oral Peptide Therapy Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Oral Peptide Therapy Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Oral Peptide Therapy Sales Market Share in Value by Type in 2022
Figure 23. Latin America Oral Peptide Therapy Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Oral Peptide Therapy Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Oral Peptide Therapy Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Oral Peptide Therapy Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Oral Peptide Therapy Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Oral Peptide Therapy Revenue in 2022
Figure 29. Oral Peptide Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Hospital
Figure 31. Global Hospital Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Product Picture of Retail Pharmacy
Figure 33. Global Retail Pharmacy Sales YoY Growth (2018-2029) & (K Units)
Figure 34. Global Oral Peptide Therapy Sales by Application (2018-2029) & (US$ Million)
Figure 35. Global Oral Peptide Therapy Sales Market Share by Application in 2022 & 2029
Figure 36. North America Oral Peptide Therapy Sales Market Share in Volume by Application in 2022
Figure 37. North America Oral Peptide Therapy Sales Market Share in Value by Application in 2022
Figure 38. Europe Oral Peptide Therapy Sales Market Share in Volume by Application in 2022
Figure 39. Europe Oral Peptide Therapy Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Oral Peptide Therapy Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Oral Peptide Therapy Sales Market Share in Value by Application in 2022
Figure 42. Latin America Oral Peptide Therapy Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Oral Peptide Therapy Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Oral Peptide Therapy Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Oral Peptide Therapy Manufacturing Cost Structure
Figure 47. Oral Peptide Therapy Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries